secwatch.observer — SEC 8-K summary
======================================

Issuer:     TACTILE SYSTEMS TECHNOLOGY INC (TCMD)
CIK:        0001027838
Form:       8-K
Filed at:   2023-11-06T23:59:59+00:00
Accession:  0001558370-23-017786
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tactile Medical Q3 revenue $69.6M (+7% YoY); net income $22.3M vs loss; updates FY guidance
--------------------------------------------------------------------------------

- Revenue $69.6M, up 7% YoY; lymphedema +15%, airway clearance -36%.
- Net income $22.3M ($0.94 diluted EPS) vs loss of $2.3M ($0.11 loss) in Q3 2022.
- Adjusted EBITDA $7.7M vs $7.2M; operating income $8.0M vs loss of $1.6M.
- FY2023 revenue guidance narrowed to $273-277M from $274-278M, ~11-12% growth.
- Sherri Ferstler appointed SVP Sales; Vindell Washington, M.D. added to Board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1027838/000155837023017786/0001558370-23-017786-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1027838/000155837023017786/tcmd-20231106x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-017786

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer